Back

Live panel discussion.

27 August 2021 (13:30 - 13:45)
Organised by:
Congress Presentation Part of: Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists Risk Factors and Prevention Open Access ESC Congress 2021 - The Digital Experience

3 More presentations in this session

Presentation thumbnail
Glucagon-like peptide 1 receptor agonists & cardiovascular outcomes: What have we learned?
Associate Professor M. Cavender (Chapel Hill, US)
Video
Presentation thumbnail
Cardiovascular effects of glucagon-like peptide 1 receptor agonists.
Doctor M. Husain (Toronto, CA)
Video
Presentation thumbnail
Glucagon-like peptide 1 receptor agonist use in cardiology.
Professor M. Petrie (Glasgow, GB)
Video

Access the full session

Session thumbnail
Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 13:30 CET
You may be interested in
thumbnail
Congress Session
A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future
27 August 2023
thumbnail
Congress Presentation
Charting the future: panel discussion and Q&A
29 August 2025
thumbnail
Congress Presentation
Roundtable discussion - Q&A
31 August 2025
thumbnail
Congress Presentation
Discussion – Pre-diabetes and metabolic syndrome: what are they and what do they mean for cardiovascular risk
13 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources